Private businesses that give away all profits and also succeed as businesses are scarce; the Newman’s Own food branding ...

Vertex Pharmaceuticals (NASDAQ: VRTX) had a fine Tuesday on the stock exchange. The biotech's shares closed the day nearly 3% ...

Here are two stocks with buy rank and strong value characteristics for investors to consider today, April 23: Phio ...

When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects.

The Fed’s interest rate pause, closed capital markets, the tariff storm, and mass layoffs at the U.S. FDA create a ...

The Nasdaq joined the Dow with a 2.7% gain. The Russell 2000 kept pace with the major indexes, also posting a 2.7% jump.

Neurocrine Biosciences' valbenazine shows promise as an adjunctive therapy for Schizophrenia, with phase 3 data expected in ...

UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...

BridgeBio Pharma's robust pipeline, favorable policy shifts, and milestone payments position it for substantial future growth ...

That kind of revenue growth makes the financial results from 100-baggers like Afterpay ( ASX: APT) and Pro Medicus ( ASX: PME ...

Spencer supplements those picks with riskier, high-growth companies, such as early-stage biotech stocks. This increasingly important industry in the small-growth realm is managed in close dialogue ...

Eupraxia Pharmaceuticals Inc.’s EPRX share price has surged by 5.46%, which has investors questioning if this is right time ...